The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size.

Trial Profile

The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2016

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms NOMI
  • Sponsors INO Therapeutics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2012 Planned patient number is 230 according to European Clinical Trials Database.
    • 28 Sep 2008 Actual patient number changed from 19 to 29 as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top